{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T06:08:22Z","timestamp":1682316502577},"reference-count":10,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":1660,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1111\/j.1468-1331.2010.03343.x","type":"journal-article","created":{"date-parts":[[2011,2,14]],"date-time":"2011-02-14T12:16:29Z","timestamp":1297685789000},"page":"e60-e61","source":"Crossref","is-referenced-by-count":1,"title":["Response to EFNS guidelines on treatment of Dystonia article"],"prefix":"10.1111","volume":"18","author":[{"given":"N.","family":"Murray","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2011,2,14]]},"reference":[{"key":"10.1111\/j.1468-1331.2010.03343.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1212\/WNL.53.7.1431","article-title":"Safety and efficacy of NeuroBloc (botulinum toxin type B) in type A-resistant cervical dystonia","volume":"53","author":"Brin","year":"1999","journal-title":"Neurology"},{"key":"10.1111\/j.1468-1331.2010.03343.x-BIB2|cit2","unstructured":"Ferreira JJ Lew MF Immunogenicity Analysis from an Extension of a Randomised, Double-Blind Trial Comparing Botulinum Neurotoxin Type B vs. Type A in Previously Toxin-Na\u00efve Patients with Cervical Dystonia: Study 402CD-EU"},{"key":"10.1111\/j.1468-1331.2010.03343.x-BIB3|cit3","unstructured":"Ferreira JJ Lew MF An Open-Label Safety and Immunogenicity Study of Botulinum Neurotoxin Type B in Patients with Cervical Dystonia: Study 401CD-EU"},{"key":"10.1111\/j.1468-1331.2010.03343.x-BIB4|cit4","unstructured":"Chinnapongse R Lew MF Pagan F Reinhard S Birmingham W A 7-Year Open-Label Safety and Immunogenicity Study of Myobloc\u00ae\/Neurobloc (RimabotulinumtoxinB; BoNT-B) in Patients with Cervical Dystonia: Study 401CD-NA"},{"key":"10.1111\/j.1468-1331.2010.03343.x-BIB5|cit5","unstructured":"Lew MF An Open-Label Long-Term Safety and Immunogenicity Study of Botulinum Neurotoxin Type B in Patients with Cervical Dystonia: Study 351"},{"key":"10.1111\/j.1468-1331.2010.03343.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/mds.21724","article-title":"Botulinum toxin type B vs type A in toxin-na\u00efve patients with cervical dystonia: randomized, double-blind, noninferiority trial","volume":"23","author":"Pappert","year":"2007","journal-title":"Mov Disord"},{"key":"10.1111\/j.1468-1331.2010.03343.x-BIB7|cit7","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1212\/01.wnl.0000183055.81056.5c","article-title":"Comparison of botulinum toxin serotypes A and B for the treatment of cervical dystonia","volume":"65","author":"Comella","year":"2005","journal-title":"Neurology"},{"key":"10.1111\/j.1468-1331.2010.03343.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1212\/01.wnl.0000249308.66959.43","article-title":"Clinico-immunologic aspects of botulinum toxin type B treatment of cervical dystonia","volume":"67","author":"Jankovic","year":"2006","journal-title":"Neurology"},{"key":"10.1111\/j.1468-1331.2010.03343.x-BIB9|cit9","first-page":"A290","article-title":"A 4\u2003year observational study of repeated dosing with botulinum toxin type B in patients with cervical dystonia [Abstract P05.127]","volume":"66","author":"Lew","year":"2006","journal-title":"Neurology"},{"key":"10.1111\/j.1468-1331.2010.03343.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1002\/mds.20531","article-title":"Efficacy and safety of repeated doses of botulinum toxin type B in type A resistant and responsive cervical dystonia","volume":"20","author":"Factor","year":"2005","journal-title":"Mov Disord"}],"container-title":["European Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1468-1331.2010.03343.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1468-1331.2010.03343.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,5]],"date-time":"2021-07-05T22:05:24Z","timestamp":1625522724000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1468-1331.2010.03343.x"}},"subtitle":["Letter to the Editor"],"short-title":[],"issued":{"date-parts":[[2011,2,14]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2011,6]]}},"URL":"https:\/\/doi.org\/10.1111\/j.1468-1331.2010.03343.x","archive":["Portico"],"relation":{},"ISSN":["1351-5101"],"issn-type":[{"value":"1351-5101","type":"print"}],"subject":[],"published":{"date-parts":[[2011,2,14]]}}}